CME Institute E-Lert


Login | MyCME | About E-Lerts | About the CME Institute | See all CME Activities | Classifieds

Figure 1: Lifetime Prevalence of Depression in US Adults by Gender and Age Group

A Fresh Look at Monoamine Oxidase Inhibitors for Depression

Lawrence J. Cohen, PharmD, BCPP, FASHP, FCCP, FCP (Co-Chair), and David A. Sclar, BPharm, PhD (Co-Chair), et al

When was the last time you thought about prescribing an MAOI to treat your patient with depression? If you're hesitant to use this class of medications or just need more information on these agents, read this Supplement to learn about the mechanism of action of MAOIs, review which foods and drugs may need to be avoided, and find out about a newer formulation with transdermal delivery that may minimize dietary restrictions.

Supported by an educational grant from Mylan Specialty L.P. (formerly known as Dey Pharma, L.P.).

For more free CME activities, visit the CME Institute at If you are having trouble reading this E-Lert, see

To receive E-Lerts from both The Journal of Clinical Psychiatry and The Primary Care Companion, update your profile.

Find the CME Institute on Facebook
Check out
Your one-stop source for information on CNS and neurologic disorders
Get E-Lerts from! Just take a few seconds to update your profile.
You are receiving this update as a benefit of your membership.
To ensure delivery of these messages add to your address book. If you would not like to receive further E-Lerts, go to and click the "Unsubscribe from E-Lerts" link. If you are having trouble unsubscribing, contact the web administrator for assistance.
If you are having trouble with your membership, contact our circulation department. Direct any other questions or comments to the web administrator.
Please do not reply directly to this e-mail.
If you cannot read this go to
Physicians Postgraduate Press, Inc. | 850 Ridge Lake Boulevard, Suite 300 | Memphis, TN 38120
© Copyright 2012, Physicians Postgraduate Press, Inc. All rights reserved.